Operating income decreased 7.2%
Operating income changed -7.2% from the comparable as-filed period.
-$45.3M→-$48.6M3 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -7.2% from the comparable as-filed period.
Net income changed -5.7% from the comparable as-filed period.
Research & development changed +2.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.